Patients taking the immunotherapy drug Keytruda (pembrolizumab) may now have the option to take it as a quick shot instead of ...

The F.D.A. approved Merck’s injected version of its blockbuster infusion Keytruda. The company says it will be quicker and ...

Doctors are experimenting with using lower doses of blockbuster cancer drugs. It could help hundreds of thousands of lives — if pharmaceutical companies would allow it.

The FDA has approved Keytruda Qlex, a faster, under-the-skin cancer treatment offering convenience and flexibility. Here's ...

The U.S. Food and Drug Administration (FDA) has approved the subcutaneous form of Keytruda for a new 'Under-the-Skin' Option ...

Rahway: Merck, known as MSD outside of the United States and Canada, has announced that the U.S. Food and Drug Administration ...

In this week’s edition of InnovationRx, we look at a startup working to fix drug pricing, Pfizer’s obesity bet and more.

Big Pharma faces unprecedented pressure as Trump administration attempts to enforce "most favored nation" drug pricing policy ...

AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that the Japan Patent Office has issued a ...

Being Tested in Combination with MSD’s anti-PD-1 Therapy, KEYTRUDA® (pembrolizumab)CAMBRIDGE, United Kingdom, Sept. 17, 2025 ...

President Trump had intensified pressure on the Justice Department in recent days, publicly demanding that top officials ...

To confirm a diagnosis and determine the stage of the disease, your doctor will use a series of tests: Biopsy: This is the ...